Eukroma Cream: Professional-Grade Hydroquinone for Hyperpigmentation Correction
| Product dosage: 20g | |||
|---|---|---|---|
| Package (num) | Per tube | Price | Buy |
| 1 | $47.04 | $47.04 (0%) | 🛒 Add to cart |
| 2 | $38.03 | $94.09 $76.07 (19%) | 🛒 Add to cart |
| 3 | $28.36 | $141.13 $85.08 (40%) | 🛒 Add to cart |
| 4 | $23.77 | $188.17 $95.09 (49%) | 🛒 Add to cart |
| 5 | $20.82 | $235.21 $104.09 (56%) | 🛒 Add to cart |
| 6 | $19.52 | $282.26 $117.11 (59%) | 🛒 Add to cart |
| 7 | $17.59 | $329.30 $123.11 (63%) | 🛒 Add to cart |
| 8 | $16.39 | $376.34 $131.12 (65%) | 🛒 Add to cart |
| 9 | $15.79 | $423.39 $142.13 (66%) | 🛒 Add to cart |
| 10 | $15.11
Best per tube | $470.43 $151.14 (68%) | 🛒 Add to cart |
Eukroma Cream is a topical dermatological formulation containing hydroquinone as its active pharmaceutical ingredient, designed for the targeted treatment of hyperpigmentation disorders. This prescription-grade depigmenting agent works by selectively inhibiting the enzymatic conversion of tyrosine to melanin within melanocytes, thereby reducing the overproduction of pigment that leads to uneven skin tone. Clinically indicated for conditions such as melasma, chloasma, freckles, and post-inflammatory hyperpigmentation, Eukroma Cream offers a scientifically validated approach to achieving a more uniform complexion. Its efficacy is well-documented in dermatological practice, making it a trusted choice among healthcare professionals for patients seeking medical intervention for persistent skin discoloration.
Features
- Contains 2% w/w hydroquinone USP as the active depigmenting agent
- Formulated in a hydrophilic base for optimal skin penetration and spreadability
- Paraben-free and fragrance-free to minimize potential irritancy
- Manufactured under GMP conditions ensuring pharmaceutical-grade quality
- Presented in an opaque tube to protect active ingredient from light degradation
- Suitable for use on face, neck, and décolletage areas
Benefits
- Effectively lightens dark spots and patches by inhibiting melanin production
- Provides gradual and natural-looking correction of hyperpigmentation over 4-8 weeks
- Helps restore even skin tone and texture with consistent medical use
- Reduces the appearance of age spots, sun damage, and hormonal discoloration
- Can be incorporated into comprehensive skincare regimens under medical supervision
- Offers a clinically proven alternative to cosmetic brightening products
Common use
Eukroma Cream is primarily prescribed for the treatment of various forms of hyperpigmentation including melasma (mask of pregnancy), chloasma, solar lentigines (age spots), ephelides (freckles), and post-inflammatory hyperpigmentation resulting from acne, trauma, or cosmetic procedures. It is particularly effective for facial hyperpigmentation but may be used on other photo-exposed areas under medical guidance. The cream is typically applied as part of a comprehensive treatment plan that may include sun protection and other adjunctive therapies. Patients typically notice initial improvement after 4-6 weeks of regular use, with optimal results appearing after 3-4 months of continuous treatment.
Dosage and direction
Apply a thin film of Eukroma Cream to affected areas twice daily, or as directed by a healthcare professional. Gently massage into the skin until fully absorbed. Use only enough to cover the hyperpigmented areas—a pea-sized amount is typically sufficient for the entire face. Morning application should be followed by a broad-spectrum sunscreen with SPF 30 or higher. Evening application should precede bedtime. Treatment duration should not exceed 5 months continuously without medical reassessment. Do not apply to unaffected skin or areas with open wounds, abrasions, or inflammation.
Precautions
- For external use only—avoid contact with eyes, lips, and mucous membranes
- Discontinue use and consult your physician if irritation, redness, or itching develops
- Sun protection is mandatory during treatment and for several weeks thereafter
- Not recommended for use on children under 12 years of age
- Periodic medical monitoring is advised during extended treatment courses
- May cause temporary stinging or burning sensation upon application
- Do not use on sunburned or windburned skin
- Patients with sensitive skin should perform a patch test before full application
Contraindications
Eukroma Cream is contraindicated in patients with known hypersensitivity to hydroquinone or any component of the formulation. It should not be used by individuals with a history of allergic reaction to hydroquinone-containing products. Contraindicated in patients with pre-existing ochronosis (blue-black discoloration of skin and cartilage). Not recommended for use during pregnancy or breastfeeding unless specifically advised by a healthcare provider. Should not be used by patients with pre-existing kidney or liver impairment without medical supervision. Avoid use in patients with a history of melanoma or suspicious pigmented lesions.
Possible side effects
Common side effects may include mild skin irritation, redness, dryness, or stinging at the application site. These typically subside with continued use. Less frequently, patients may experience:
- Contact dermatitis
- Skin cracking or blue-black discoloration (ochronosis)
- Hypopigmentation of surrounding normal skin
- Allergic reactions including rash, hives, or swelling
- Paradoxical hyperpigmentation in some cases
- Temporary whitening of hair in treated areas
- In rare instances, exogenous ochronosis with long-term use
Drug interaction
No formal drug interaction studies have been conducted with topical hydroquinone. However, concomitant use with other topical medications containing benzoyl peroxide, hydrogen peroxide, or other oxidizing agents may cause temporary dark discoloration of the skin. Concurrent use with topical corticosteroids may enhance efficacy but also increase the risk of skin atrophy. Use with topical retinoids may increase skin irritation and photosensitivity. Patients using other depigmenting agents should consult their physician before initiating treatment with Eukroma Cream.
Missed dose
If a dose is missed, apply the cream as soon as remembered unless it is nearly time for the next application. Do not double the dose to make up for a missed application. Maintain the regular twice-daily schedule without exceeding the recommended frequency. Consistent application is important for optimal results, but occasional missed doses are unlikely to significantly affect overall treatment efficacy.
Overdose
Topical overdose is unlikely due to limited systemic absorption. However, excessive application may lead to severe skin irritation, burning, redness, or peeling. If accidental ingestion occurs, seek immediate medical attention. Symptoms of oral overdose may include tinnitus, nausea, vomiting, shortness of breath, convulsions, and cyanosis (bluish skin discoloration). Treatment is supportive and symptomatic. There is no specific antidote for hydroquinone overdose.
Storage
Store at room temperature (15-30°C) in the original container. Keep the tube tightly closed when not in use. Protect from light and excessive heat. Do not freeze. Keep out of reach of children and pets. Discard any unused product 3 months after opening or by the expiration date printed on the packaging, whichever comes first. Do not transfer to other containers.
Disclaimer
This information is provided for educational purposes only and does not constitute medical advice. Eukroma Cream is a prescription medication that should be used only under the supervision of a qualified healthcare professional. Individual results may vary. Always follow your physician’s instructions regarding use, dosage, and treatment duration. Not all possible uses, precautions, side effects, or interactions are listed here. Consult your healthcare provider for complete information appropriate to your specific medical condition.
Reviews
Clinical studies demonstrate that Eukroma Cream produces significant improvement in hyperpigmentation in approximately 70-80% of patients when used as directed for 3-4 months. Dermatologists report satisfactory to excellent results in managing melasma and post-inflammatory hyperpigmentation, particularly when combined with strict sun protection. Patient satisfaction surveys indicate noticeable lightening of dark spots within 6-8 weeks of consistent use. Some users report mild dryness or irritation during the initial weeks of treatment, which typically resolves with proper moisturization. Long-term users should be monitored for potential side effects including ochronosis, though this remains rare with proper use under medical supervision.